Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v1-EN
Language English English
Date Updated 2017-09-08 2017-09-08
Drug Identification Number 02382369 02382369
Brand name AXIRON AXIRON
Common or Proper name TESTOSTERONE TOPICAL SOLUTION , 2% TESTOSTERONE TOPICAL SOLUTION , 2%
Company Name ELI LILLY CANADA INC ELI LILLY CANADA INC
Ingredients TESTOSTERONE TESTOSTERONE
Strength(s) 2% 2%
Dosage form(s) SOLUTION SOLUTION
Route of administration TOPICAL TOPICAL
Packaging size 1 METERED-DOSE PUMP - 30MG (1.5ML) PER ACTUATION - 60 DOSES 1 METERED-DOSE PUMP - 30MG (1.5ML) PER ACTUATION - 60 DOSES
ATC code G03BA G03BA
ATC description ANDROGENS ANDROGENS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2017-12-04 2017-12-04
Actual discontinuation date 2017-12-04 2017-12-04
Remaining supply date 2017-12-04 2017-12-04
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments For any questions, please contact our Eli Lilly Canada Customer Response Center at 1-888-545-5972. Eli Lilly Canada Inc. 3650 Danforth Avenue Toronto, ON M1N 2E8
Health Canada comments